A*STAR stealth technology gets viruses past the immune system; Texas researcher gets $1.5M for pollen grain delivery system;

> A*STAR Institute of Bioengineering and Nanotechnology researchers have created a stealth technology that coats therapeutic viruses with peptide and DNA microfibers, allowing them to slip past the immune system and increase survival time in mice with cancer. Press release

> A Texas Tech University researcher has been given a 5-year, $1.5 million grant from the National Institutes of Health (NIH) to develop an oral vaccine delivery system based on pollen grains. Press release

> Protocells, silica and lipid nanoparticles show potential to target drugs to where they are needed. Article

> Startup Tangent Medical Technologies received FDA approval to sell NovaCath, its alternative to standard IV delivery systems. Article

> Silica-based delivery system could solve the riddle of oral peptide delivery. Abstract

> Pearl Therapeutics has completed a randomized, double-blind Phase IIb study of the long-acting muscarinic antagonist (LAMA), glycopyrrolate, for the treatment of COPD. Press release

> The European Medicines Agency has released draft guidelines on oral modified release products and transdermal patches. Press release | Article

> Israeli researchers create gold nanospheres that release rituximab in response to laser light. Paper (PDF)

> Nanodiamonds deliver doxorubicin. Article

And Finally… Purdue University researchers develop a drug delivery micropump powered by a tiny brewery! Article

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.